Dopamine Agonists: US FDA Orders Safety Labeling Changes But Not Boxed Warnings

 
• By Sue Sutter
  
Warning sign with exclamation mark on striped caution tape
US FDA is broadening some dopamine agonist warning language to patients with restless legs syndrome. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Drug Safety

More from Pink Sheet